GPN vs LUV

GPN presents a stark contrast between strong deterministic health and deteriorating growth. While the Piotroski F-Score of 7/9 indicates robust financial health and the stock trades significantly below its Graham Number ($98.18) and book value (P/B 0.71), these value metrics are countered by a severe collapse in earnings growth (-59.20% YoY) and a bearish technical trend (0/100). The massive discrepancy between the current P/E (15.42) and Forward P/E (4.22) suggests the market is pricing in a recovery that is not yet evident in the quarterly data. Consequently, the stock appears to be a deep-value play with significant execution risk.

LUV presents a conflicted profile with a stable but mediocre Piotroski F-Score of 4/9 and a significant valuation gap, trading at $40.92 against a Graham Number of $16.38. While the Forward P/E (8.95) and PEG (0.22) suggest strong future earnings potential and a recovery trajectory, current liquidity is concerning with a Current Ratio of 0.52. The dividend is largely unsustainable given a 91.14% payout ratio. Overall, the stock is trading at a significant premium to its intrinsic value of $22.71, though analyst targets remain slightly bullish.